Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tangier disease and ABCA1.

J F Oram1

  • 1University of Washington, Division of Metabolism, Endocrinology and Nutrition, Box 356426, Seattle, WA 98195-6426, USA. joram@u.washington.edu

Biochimica Et Biophysica Acta
|December 9, 2000
PubMed
Summary

Tangier disease causes severe high-density lipoprotein (HDL) deficiency due to ABCA1 transporter mutations. This leads to cholesterol buildup in macrophages and atherosclerosis, highlighting ABCA1 as a therapeutic target.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sterol efflux mediated by endogenous macrophage ApoE expression is independent of ABCA1.

Arteriosclerosis, thrombosis, and vascular biology·2001
Same author

ATP-binding cassette transporter A1 mediates cellular secretion of alpha-tocopherol.

The Journal of biological chemistry·2001
Same author

ABCA1. The gatekeeper for eliminating excess tissue cholesterol.

Journal of lipid research·2001
Same author

Novel approaches to treating cardiovascular disease: lessons from Tangier disease.

Expert opinion on investigational drugs·2001
Same author

Membrane lipid domains distinct from cholesterol/sphingomyelin-rich rafts are involved in the ABCA1-mediated lipid secretory pathway.

The Journal of biological chemistry·2000
Same author

ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages.

The Journal of biological chemistry·2000

Area of Science:

  • Genetics
  • Molecular Biology
  • Cardiovascular Science

Background:

  • Tangier disease is a rare genetic disorder.
  • It is characterized by severe deficiency in high-density lipoprotein (HDL).
  • It involves sterol deposition in macrophages and atherosclerosis.

Purpose of the Study:

  • To investigate the role of the ATP binding cassette transporter ABCA1 in Tangier disease.
  • To understand the mechanism of HDL deficiency and cholesterol accumulation.
  • To identify ABCA1 as a potential therapeutic target for atherosclerosis.

Main Methods:

  • Genetic analysis of mutations in the ABCA1 gene.
  • Cellular studies on cholesterol and phospholipid secretion.
  • Analysis of apolipoprotein metabolism and degradation.

Main Results:

  • Mutations in ABCA1 cause Tangier disease and familial HDL deficiencies.
  • ABCA1 facilitates cholesterol and phospholipid secretion to apolipoproteins.
  • Impaired ABCA1 function leads to cholesterol over-accumulation in macrophages.

Conclusions:

  • ABCA1 is critical for reverse cholesterol transport.
  • ABCA1 dysfunction contributes to atherosclerosis development.
  • Targeting ABCA1 may offer a therapeutic strategy for cholesterol clearance and atherosclerosis prevention.

Related Experiment Videos